9-134801982-GC-GCC
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_000093.5(COL5A1):c.2988dupC(p.Gly997ArgfsTer17) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000958 in 1,460,988 control chromosomes in the GnomAD database, with no homozygous occurrence. There is a variant allele frequency bias in the population database for this variant (GnomAdExome4), which may indicate mosaicism or somatic mutations in the reference population data. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. G997G) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000093.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- Ehlers-Danlos syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome, classic typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
- Ehlers-Danlos syndrome, classic type, 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- arterial disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL5A1 | NM_000093.5 | c.2988dupC | p.Gly997ArgfsTer17 | frameshift_variant | Exon 38 of 66 | ENST00000371817.8 | NP_000084.3 | |
| COL5A1 | NM_001278074.1 | c.2988dupC | p.Gly997ArgfsTer17 | frameshift_variant | Exon 38 of 66 | NP_001265003.1 | ||
| COL5A1 | XM_017014266.3 | c.2988dupC | p.Gly997ArgfsTer17 | frameshift_variant | Exon 38 of 65 | XP_016869755.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL5A1 | ENST00000371817.8 | c.2988dupC | p.Gly997ArgfsTer17 | frameshift_variant | Exon 38 of 66 | 1 | NM_000093.5 | ENSP00000360882.3 | ||
| COL5A1 | ENST00000371820.4 | c.2988dupC | p.Gly997ArgfsTer17 | frameshift_variant | Exon 38 of 66 | 2 | ENSP00000360885.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000240 AC: 6AN: 250458 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1460988Hom.: 0 Cov.: 32 AF XY: 0.00000826 AC XY: 6AN XY: 726804 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (Lek et al., 2016); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Reported in ClinVar as a pathogenic variant (ClinVar Variant ID# 459667; Landrum et al., 2016); This variant is associated with the following publications: (PMID: 22696272, 23587214)
Ehlers-Danlos syndrome, classic type, 1 Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gly997Argfs*17) in the COL5A1 gene. It is expected to result in an absent or disrupted protein product. This variant has been reported in individuals affected with Ehlers–Danlos syndrome (PMID: 22696272, 23587214). ClinVar contains an entry for this variant (Variation ID: 459667). Loss-of-function variants in COL5A1 are known to be pathogenic (PMID: 23587214). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at